Shreyas Joshi

CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor

Nataliya Prokhnevska, Maria A. Cardenas, Rajesh M. Valanparambil et al. · Immunity · 2022 · 308 citations · Full text

Radiation Oncology, Effector Differentiation, Cancer Immunosurveillance +8

18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial

Ashesh B. Jani, Eduard Schreibmann, Subir Goyal et al. · The Lancet · 2021 · 178 citations · Full text

Positron Emission Tomography, Surgical Oncology, Postprostatectomy Salvage Radiotherapy +15

Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches

Paolo Gontero, Giancarlo Marra, Paolo Alessio et al. · The Journal of Urology · 2019 · 89 citations

Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)

Devaki Shilpa Surasi, Matthias Eiber, Tobias Maurer et al. · European Urology · 2023 · 86 citations · Full text

Prognostic role of Oct4, CD44 and c-Myc in radio–chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient mice

Sharada Sawant, Ravindran Caspa Gokulan, Harsh Dongre et al. · Clinical Oral Investigations · 2015 · 70 citations

Cancer Immunosurveillance, Oncology, Prognostic Role +13